Category Archives: The One-on-One Compass

BIO’s Next Generation Partnering System to Open April 2015

partnering-HP-300x312

You’ve found your lead investor. Now it’s time to get to the next stage, and the best place to do so is the 2015 BIO International Convention. You have a meeting with Pfizer at 9:00 a.m. followed by a meeting with AstraZeneca/MedImmune at 9:30 a.m. Then a 30 minute break. Then you have four meetings back to back with Sofinnova, Takeda Ventures, Gates Foundation and Merck. After a quick lunch it’s back to partnering: make Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Investor Forum Company Snapshot: Syntrix Biosystems

SyntrixBioLogo_3D

1.     What is your company’s lead product or technology? Omnitram (O-desmethyltramadol) is a novel  oral analgesic developed by Syntrix that alleviates pain via a dual mechanism involving mu-opioid receptor activation and inhibition of the reuptake of norepinephrine.  Omnitram is in clinical development and has just completed a Phase 1b double-blind, placebo-controlled clinical trial (N=40) in experimental pain. 2.     What sets your company apart from competitors? Omnitram is a proprietary solution for pain relief that is Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

Understanding the Biotech Market in Brazil

LatinAmerica_205x100_Thumbnail copy

The biotechnology market in Brazil has seen enormous activity this year in both the areas of industrial biotechnology and healthcare. In a recent webinar that discussed the latest results of the annual Scientific American Worldview report, panelists were especially excited by the partnering opportunities in Brazil. Mike May, Editorial Director, Scientific American Worldview, commented, “Brazil is, as a country, like a master of partnering. They partner in the country between industry and government. They partner Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Partner with Top Asian Biopharma Executives at BIO Asia

Asia2013_115x76_Thumbnail copy

On April 8-9, 2014, a diverse group of innovative companies and Japanese dealmakers will come together in a collaborative setting for partnering meetings, company presentations, networking and targeted programming at the 11th annual BIO Asia International Conference. Japan’s presence as the 2nd largest pharmaceutical industry in the world, bolstered by an evolving Asia-Pacific partnering landscape, means biopharma companies cannot ignore the deal opportunities that are being created in this dynamic market. Industry leaders have recognized Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

Find Your Next Asia Partnership in Tokyo at BIO Asia

Asia2013_115x76_Thumbnail copy

On April 8-9, 2014, the BIO Asia International Conference will enter its eleventh year. This year, biopharma industry leaders will convene at the Grand Hyatt in Tokyo, Japan to make the cross border deals that will advance collaboration between Asia and the West. This event has become the premier customized partnering event for Western and Asian biopharma executives. According to JP Morgan healthcare specialist Scott Braunstein, Japan has become one of the most critical markets for pharma Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,